Madariaga Leire, García-Castaño Alejandro, Ariceta Gema, Martínez-Salazar Rosa, Aguayo Aníbal, Castaño Luis
Pediatric Nephrology Department, Cruces University Hospital, UPV/EHU, Barakaldo, Spain.
Biocruces Health Research Institute, Barakaldo, Spain.
Clin Kidney J. 2018 Nov 13;12(3):373-379. doi: 10.1093/ckj/sfy102. eCollection 2019 Jun.
Mutations in () have been associated with congenital anomalies of the kidney and urinary tract (CAKUT) in humans. Diabetes and other less frequent anomalies have also been described. Variable penetrance and intrafamilial variability have been demonstrated including severe prenatal phenotypes. Thus, it is important to differentiate this entity from others with similar clinical features and perform confirmatory molecular diagnosis.
This study reports the results of screening in a cohort of 60 patients from 58 unrelated families presenting with renal structural anomalies and/or non-immune glucose metabolism alterations, and other minor features suggesting mutations.
This study identified a pathogenic variant in 23 patients from 21 families. The most frequent finding was bilateral cystic dysplasia or hyperechogenic kidneys (87% of patients). Sixty percent of them also fulfilled the criteria for impaired glucose metabolism, and these were significantly older than those patients with an mutation but without diabetes or prediabetes (14.4 versus 3.3 years, P < 0.05). Furthermore, patients with mutations had higher frequency of pancreatic structural anomalies and hypomagnesaemia than patients without mutations (P < 0.001 and P = 0.003, respectively). Hyperuricaemia and increased liver enzymes were detected in some patients as well.
Renal anomalies found in patients with mutations are frequently unspecific and may resemble those found in other renal pathologies (CAKUT, ciliopathies). Active searching for extrarenal minor features, especially pancreatic structural anomalies or hypomagnesaemia, could support the indication for molecular diagnosis to identify mutations.
(基因)突变与人类先天性肾脏和尿路异常(CAKUT)有关。糖尿病和其他不太常见的异常情况也有报道。已证实存在可变外显率和家族内变异性,包括严重的产前表型。因此,将该实体与具有相似临床特征的其他实体区分开来并进行确诊性分子诊断很重要。
本研究报告了对来自58个无关家庭的60例患者进行筛查的结果,这些患者表现为肾脏结构异常和/或非免疫性糖代谢改变,以及其他提示(基因)突变的轻微特征。
本研究在来自21个家庭的23例患者中鉴定出一种致病变体。最常见的发现是双侧囊性发育不良或肾回声增强(87%的患者)。其中60%的患者也符合糖代谢受损的标准,且这些患者的年龄明显大于那些有(基因)突变但无糖尿病或糖尿病前期的患者(14.4岁对3.3岁,P<0.05)。此外,有(基因)突变的患者胰腺结构异常和低镁血症的发生率高于无突变的患者(分别为P<0.001和P = 0.003)。在一些患者中还检测到高尿酸血症和肝酶升高。
有(基因)突变的患者中发现的肾脏异常通常不具有特异性,可能类似于其他肾脏疾病(CAKUT、纤毛病)中发现的异常。积极寻找肾外轻微特征,尤其是胰腺结构异常或低镁血症,可能有助于支持进行分子诊断以鉴定(基因)突变的指征。